GR3018687T3 - Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs. - Google Patents

Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs.

Info

Publication number
GR3018687T3
GR3018687T3 GR960400088T GR960400088T GR3018687T3 GR 3018687 T3 GR3018687 T3 GR 3018687T3 GR 960400088 T GR960400088 T GR 960400088T GR 960400088 T GR960400088 T GR 960400088T GR 3018687 T3 GR3018687 T3 GR 3018687T3
Authority
GR
Greece
Prior art keywords
drugs
preparation
compound
histamine derivatives
imidazolyl
Prior art date
Application number
GR960400088T
Other languages
English (en)
Inventor
Jean Charles Schwartz
Monique Garbarg
Jean Michel Arrang
Charon Robin Ganellin
Jeanne Marie Lecomte
Abdellatif Fkyerat
Original Assignee
Bioprojet Soc Civ
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet Soc Civ, Inst Nat Sante Rech Med filed Critical Bioprojet Soc Civ
Publication of GR3018687T3 publication Critical patent/GR3018687T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR960400088T 1991-09-06 1996-01-17 Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs. GR3018687T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/754,914 US5321039A (en) 1990-04-13 1991-09-06 Method of inducing a histamine agonist action on H2 receptors

Publications (1)

Publication Number Publication Date
GR3018687T3 true GR3018687T3 (en) 1996-04-30

Family

ID=25036925

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400088T GR3018687T3 (en) 1991-09-06 1996-01-17 Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs.

Country Status (8)

Country Link
US (1) US5321039A (el)
EP (1) EP0531219B1 (el)
JP (1) JPH0687742A (el)
AT (1) ATE131052T1 (el)
DE (1) DE69206536T2 (el)
DK (1) DK0531219T3 (el)
ES (1) ES2080466T3 (el)
GR (1) GR3018687T3 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
US6028095A (en) * 1998-10-15 2000-02-22 Warner-Lambert Company Treatment of inflammatory bowel disease using histamine H3 -receptor agonists
AU3033100A (en) 1999-01-18 2000-08-01 Boehringer Ingelheim International Gmbh Substituted imidazoles, their preparation and use
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
US6610721B2 (en) 2000-03-17 2003-08-26 Novo Nordisk A/S Imidazo heterocyclic compounds
US7501431B2 (en) * 2003-03-31 2009-03-10 Meui Seika Kaisha, Ltd. Physiologically active substances PF1270A, B and C substances
AU2004274309B2 (en) 2003-09-22 2010-04-08 Msd K.K. Novel piperidine derivative
US20100137391A1 (en) 2005-09-15 2010-06-03 Ryo Yoshimoto Histamine H3 Agonist for use as Therapeutic Agent for a Lipid/Glucose Metabolic Disorder
AU2011315793B2 (en) 2010-10-14 2014-03-06 Unilever Plc Laundry detergent particles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818097A (en) * 1969-10-29 1974-06-18 Smith Kline French Lab Method of inhibiting histamine activity with isothioureas
US3891764A (en) * 1969-10-29 1975-06-24 Smith Kline French Lab Method of inhibiting histamine activity with amidine derivatives
BE758145A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Iso-thio-urees et derives
US3759944A (en) * 1970-10-14 1973-09-18 Smith Kline French Lab Isothioureas and their derivatives
US4000302A (en) * 1972-04-20 1976-12-28 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
US3954982A (en) * 1972-04-20 1976-05-04 Smith Kline & French Laboratories Limited Pharmaceutical compositions and method of inhibiting H-1 and H-2 histamine receptors
GB8916947D0 (en) * 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments
FR2660862B1 (fr) * 1990-04-13 1994-09-23 Bioprojet Soc Civ Application therapeutique de derives de l'histamine, nouveau derive de l'histamine et utilisation de ces derives pour la preparation de medicaments.

Also Published As

Publication number Publication date
DE69206536D1 (de) 1996-01-18
US5321039A (en) 1994-06-14
JPH0687742A (ja) 1994-03-29
ES2080466T3 (es) 1996-02-01
EP0531219B1 (en) 1995-12-06
EP0531219A1 (en) 1993-03-10
DK0531219T3 (da) 1996-01-08
ATE131052T1 (de) 1995-12-15
DE69206536T2 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
GR3018687T3 (en) Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs.
DE59310323D1 (de) Imidazol-derivate mit Biphenylsulfonylharnstoff- oder Biphenylsulfonylurethan-Seitenkette, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0628311A4 (en) ANTIDEPRESSANT.
DE59309360D1 (de) Guanidinalkyl-1, 1-bisphosphonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
AU6785587A (en) New dihydrobenzofuran- and chroman-carboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics
GR3023083T3 (en) Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments
ES2052954T3 (es) Derivados de imino-2-polifluoroalcoxi-6-benzotiazol, sus procedimientos de preparacion y los medicamentos que les contienen.
PT88542A (pt) Processo para a preparacao de compostos derivados de pirimidina, imidazolina e diazepina
NO943688D0 (no) Fremgangsmåte for fremstilling av 4-pyridyl- og 4-piperidinylimidazoler som er nyttige som mellomprodukter for syntese av histaminreseptorantagonister
GB2264492B (en) Benzodiazepine derivatives
ZA868685B (en) Process for the preparation of n-cyano-n'-methyl-n"-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)-
ES8401065A1 (es) Procedimiento para preparar derivados de benzotiadiazol-amina.
PT84618B (de) Bis-tertiaerbutylamino-substituierte 1,3,5-triazinderivate verfahren zu ihrer herstellung diese verbindungen enthaltende arzneimittel und ihre verwendung
EP0433749A3 (de) Pyrazolin-5-on-Derivate
FI905912A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 6-(1-hydroksietyyli)-3-(substituoitu tio)-7-okso-1-atsabisyklo/3.2.0/hept-2-eeni-2-karboksyylihappojohdannaisten valmistamiseksi
PH24990A (en) 1-(1 aryl-2-hydroxyethyl)-imidazoles and salts thereof
ES551110A0 (es) Procedimiento para la obtencion de derivados de 1-(2,4-diclorofenil)-2-(1-imidazolil)etanol
EP0197189A3 (de) 1,3,4-Thiadiazolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
IL80666A0 (en) Process for the preparation of n-cyano-n'-methyl-n"-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)guanidine
IT8922002A0 (it) Procedimento per la preparazione di n-ciano-n'-metil-n"-(2-(((5-metil1h-imidazol-4-il)metil)tio)etil)guanidina
ES549019A0 (es) Procedimiento para la obtencion de la 1-((4-fluorfenil)me- til)-n-(1-(2-(4-metoxifenil)etil)-4-piperidinil)-1h-bencimi-dazol-2-amina
AR230981Q (es) Un procedimiento para la preparacion de derivados de 4-(6'-metoxi-2'-naftil)butan-2-ona
ES536803A0 (es) Procedimiento para la obtencion de la (1-amino-3(((2-((diamino-metilen) amino)-4-tiazolil)metil)tio)propiliden)sulfamida
IT1298492B1 (it) Uso di composti agonisti beta3-adrenergici per la preparazione di farmaci capaci di indurre la liberazione dell'ormone "glp-1"
BR9205461A (pt) Processo para preparar um composto,composto um 3,3-dimetil-4,6,6-tricloro 7,7,7-trifluoroheptanoato de metila,de etila,ou de 2,6-diclorobenzila